LYSSAVIRUS ANTIGEN CONSTRUCTS
Nucleic acid based vaccine constructs encoding Lyssaviral antigens are useful in preventing and treating diseases. Self-amplifying RNA molecules encoding Lyssaviral antigens provide potent and long-lasting immunity.
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
04.08.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Nucleic acid based vaccine constructs encoding Lyssaviral antigens are useful in preventing and treating diseases. Self-amplifying RNA molecules encoding Lyssaviral antigens provide potent and long-lasting immunity. |
---|---|
Bibliography: | Application Number: US202217591421 |